B

Biome Australia Ltd
ASX:BIO

Watchlist Manager
Biome Australia Ltd
ASX:BIO
Watchlist
Price: 0.565 AUD Market Closed
Market Cap: 123.8m AUD
Have any thoughts about
Biome Australia Ltd?
Write Note

Net Margin
Biome Australia Ltd

-12.4%
Current
-20%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-12.4%
=
Net Income
-1.7m
/
Revenue
13.4m

Net Margin Across Competitors

Country AU
Market Cap 121.5m AUD
Net Margin
-12%
Country FR
Market Cap 176B EUR
Net Margin
15%
Country UK
Market Cap 117.3B GBP
Net Margin
11%
Country IN
Market Cap 5.7T INR
Net Margin
17%
Country UK
Market Cap 34.7B GBP
Net Margin
11%
Country DE
Market Cap 27.7B EUR
Net Margin
8%
Country US
Market Cap 25.1B USD
Net Margin
1%
Country JP
Market Cap 2.9T JPY
Net Margin
5%
Country IN
Market Cap 1.2T INR
Net Margin
-3%
Country IN
Market Cap 909.1B INR
Net Margin
14%
Country US
Market Cap 10.2B USD
Net Margin
12%
No Stocks Found

Biome Australia Ltd
Glance View

Market Cap
121.5m AUD
Industry
Consumer products

Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-30. The firm licenses, develops and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products include 22 products marketed under three brands, being Activated Probiotics, Activated Nutrients and Activated X Performance. These products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trials.

BIO Intrinsic Value
0.322 AUD
Overvaluation 43%
Intrinsic Value
Price
B

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-12.4%
=
Net Income
-1.7m
/
Revenue
13.4m
What is the Net Margin of Biome Australia Ltd?

Based on Biome Australia Ltd's most recent financial statements, the company has Net Margin of -12.4%.